Fabtech Technologies Cleanrooms Ltd (BSE: 544332, NSE: FABCLEAN) — Business Report / Investor Feed

Business & Distribution Evaluation: Fabtech Technologies Cleanrooms Ltd (BSE: 544332)

1. Business Identity

Fabtech Technologies Cleanrooms Limited (FTCL) is a manufacturer of pre-engineered, pre-fabricated modular cleanroom panels and doors, and a provider of end-to-end turnkey cleanroom and HVAC solutions for pharmaceutical, biotech, semiconductor, renewable energy, data centre, and allied industries, operating primarily in India with emerging international presence [27] [66]. The company operates as a single reported segment — turnkey cleanroom solutions — and does not report segment-wise revenue under AS-17 [60] [49].

2. Revenue Architecture

Revenue Model

Project-based / product-sales + installation services model. Revenue is recognised on transfer of risks/rewards for product sales and on rendering for installation & commissioning services [40]. Contracts are awarded via Letters of Intent (LOIs) at fixed consideration exclusive of taxes [5] [12].

Consolidated Revenue Trend (₹ in Lakhs)

Sources: [19] [34] [45]

FY25 consolidated revenue grew 54.1% YoY to ₹150.03 crore, with EBITDA up 88.2% YoY and PAT surging 138.9% YoY [45]. H2 FY25 revenue was ₹88.10 crore, up 52.8% over H2 FY24, with net profit of ₹7.95 crore, up 55.7% YoY [45]. FY24 consolidated revenue (₹97.39 crore) was a trough following ₹124.67 crore in FY23, indicating cyclicality in order flows [19].

The FY24 revenue trough (₹97.39 crore, down 22% from FY23) followed by an aggressive FY25 rebound (₹150.03 crore, up 54%) highlights the inherent lumpiness of project-based revenue streams. Margin expansion from 5.6% EBITDA [FY22] to 11.3% [FY25] suggests operating leverage is kicking in, but sustainability depends on order flow consistency.

Consolidated Revenue Mix by Nature [FY25] (₹ in Lakhs)

Source: [46]

Standalone Revenue Mix by Nature [FY25] (S) (₹ in Lakhs)

Source: [6]

Revenue by Business Vertical (Order Inflows as Proxy)

Monthly order updates provide a vertical split between Cleanroom Partitions (panels, doors, accessories) and HVAC Systems:

Sources: [4] [33] [20] [23] [37] [26]

Geographic Revenue Split (S) (₹ in Lakhs)

Source: [70] [6]. Export share rose from ~1.2% [FY24] to ~9.3% [FY25].

Note: There is a minor discrepancy in FY24 export FOB values between filings: [10] reports ₹216.69 lakhs while [70] reports ₹100.11 lakhs. The annual report [70] is the more authoritative source.

Standalone vs. Consolidated Split [FY25]

Management noted approximately a 50:50 revenue contribution between Fabtech standalone and Kelvin (HVAC subsidiary) at the consolidated level [25]. Standalone revenue was ₹139.18 crore vs. consolidated ₹150.03 crore, implying Kelvin contributed ~₹10.85 crore net of intercompany eliminations [38] [9].

Kelvin standalone turnover: ₹43.44 crore [FY25], ₹30.04 crore [FY24], ₹25.37 crore [FY23] [44]. H1 FY26 revenue: ₹26.08 crore with PAT of ₹1.63 crore [64].

Q3 FY26 Revenue Update

Consolidated revenue of ₹39.86 crore in Q3 FY26 vs. ₹38.33 crore in Q3 FY25 [23].

Related Party Sales [FY25] (S) (₹ in Lakhs)

Source: [69]

Related party sales of ₹28.16 crore represent ~20.2% of standalone revenue [FY25], with FTL alone at ~10.9% and UAE-based entities contributing ~8.8%. These transactions are described as "significant from a revenue perspective" [63].

Related-party sales at ~20% of standalone revenue create a dual risk: revenue dependency on the promoter group's FTL ecosystem, and the inherent difficulty in verifying arm's-length pricing on intra-group transactions. The ₹12.21 crore routed through UAE entities warrants particular scrutiny as the company sets up its own UAE WOS.

Pricing Mechanism

Not explicitly disclosed. The project-based, order-by-order nature — with orders at fixed consideration exclusive of taxes [5] [12] — suggests fixed-price contracts with limited cost pass-through. Management highlighted value engineering as a key profitability lever [45].

Revenue Guidance

Management guided 30%–40% growth for FY26, with post-2027 described as "the real growth story" [67]. They characterised FY26 as a "foundation year" focused on building references and prestige-grade infrastructure [56].

3. Product & Service Portfolio

Core Offerings

Key Differentiators

• Integrated design-build-manufacture model: In-house design team + manufacturing + project management — most competitors are pure contractors [22] [52]
• FM Global certified cleanroom partitions (fire safety compliance) [65] [50]
• ISO 9001:2015 certified; 20+ years of industry experience; 2,000+ clients served [28]
• In-house technology: No outside technology used; entire R&D directed at product improvement [11]
• State-of-the-art manufacturing facility — significant capacity barrier to new entrants [22]
• Wall panels feature radius corners, non-porous surfaces, resistance to microbial growth [50]

Recent Launches & Pipeline

• First semiconductor order — CG Semi, ₹8.4 crore [25] [31]; data centre and semiconductor references achieved "nine months before time" [52]
• Largest single order in history: ₹68 crore from a leading solar PV module manufacturer [Oct 2025] [5] [4]
• ₹33 crore order from a solar energy storage systems company [Dec 2025] [13] [35]
• New panels under development: "There are new panels coming in. We are launching them" [30]
• Eurovent certification applied for Advantek AHUs [16]
• Proof of concept completed with SoftTech and Galentic Pharma for modular partition + HVAC integrated offering [52]

4. Value Chain Position

Position in the Value Chain

FTCL operates as a designer → manufacturer → installer of cleanroom infrastructure. It sits between raw material suppliers and end-user pharmaceutical/semiconductor/solar manufacturing facilities. The company also acts as a subcontractor to turnkey EPC players like Tata Projects (e.g., for Micron semiconductor project) [1] [29] and as a component supplier to related-party FTL for its international turnkey projects [63].

Raw Material Suppliers → FTCL (Design + Manufacture + Install) → End-Use Facilities
(Steel, Aluminium,        (Panels, Doors, HVAC, MEP)           (Pharma plants, Solar
 Insulation, Chemicals)                                          fabs, Data centres)

Management described the strategy as "creating a truly unique design build setup with in-house manufacturing of most of the critical components" [52].

Direction of Integration — Both Backward & Forward

Kelvin stake progression: 33.33% → 51.33% (IPO-funded acquisition, Apr 2025) [59] → 60.53% (additional 9.2% for ₹4.65 crore, Jan 2026) [48], with management confirming further increase is "in the pipeline" [68].

IPO Proceeds Utilisation [H1 FY26]

All ₹27.74 crore IPO proceeds fully utilised: ₹14.00 crore for working capital, ₹5.50 crore for Kelvin acquisition, ₹4.96 crore for general corporate purposes, ₹3.29 crore for issue expenses [49].

Key Inputs & Material Consumption (Consolidated) [FY25] (₹ in Lakhs)

Source: [46]

Steel coils and sheets alone constitute 46% of raw material costs, creating meaningful exposure to steel price cycles. With material consumption at ~69% of revenue and fixed-price contracts offering limited cost pass-through, a sustained steel price spike could compress margins materially. The 99.8% domestic sourcing base [70] mitigates forex risk but concentrates commodity exposure.

Supplier Concentration & Sourcing

• 99.80% indigenous raw material procurement [FY25]; only 0.20% imported (₹19.20 lakhs) [70]
• Major raw materials: GPSC coil, rockwool, isocyanate and polyol chemicals, aluminium profile [68]
• Long-standing vendor relationships for steel/coil with "national big names"; diversified domestic sourcing base — no single-source dependency disclosed [1]
• Management has a stated strategy of "taking a lot of our vendors in our fold" through acquisitions [58]

Cost Structure [FY25]

5. Distribution Architecture

Channel Structure

FTCL operates a direct B2B project-based model. There are no dealers, distributors, or retail channels. Revenue is generated through:

1. Direct sales force & project management teams stationed pan-India and internationally [22]
2. Subcontracting / channel partnerships — acting as a specialist subcontractor to EPC firms like Tata Projects for large semiconductor/infrastructure projects [29]
3. Related-party channel — Fabtech Technologies Limited (FTL) sources modular panels and doors from FTCL as part of its international turnkey projects (₹15.23 crore [FY25]) [69]; UAE-based entities FTS Cleanrooms Systems LLC and FVE Lifecare (₹12.21 crore combined [FY25]) [69]
4. M&A-driven geographic expansion — acquiring companies in target regions "to get foothold in the regions that we are wishing to expand" [52]

Channel depth: 0–1 intermediary (direct to end client, or via EPC contractor/related party).

Network Scale

Geographic Coverage

• Domestic: Pan-India across pharma hubs and emerging solar/semiconductor manufacturing clusters [22]. Hyderabad expansion specifically targets the southern pharmaceutical ecosystem [47]
• International: UAE WOS under incorporation [54]; exports to UAE via related-party entities [69]
• Export revenue share: ~9.3% of standalone revenue [FY25], up from ~1.2% [FY24] [70]

Digital Distribution

Not applicable — the company operates in project-based B2B infrastructure; no e-commerce or digital distribution channel disclosed.

Channel Economics

• Post-delivery model: One-year defect liability/warranty period; optional manpower support for 24x7 operations if requested [24]
• Collection process: Internal targets for salespeople; restructuring of collection methodology underway [36]

Distribution Moat

• Reference-based selling: Successful project execution creates "gold standard" references — e.g., a single solar reference project unlocked pan-India access to that sector [39]
• Integrated design-build-manufacture capability is difficult to replicate: "If there is anybody who is wanting to start modular partition manufacturing today, he will have a huge challenge of meeting those volumes" [22]
• Domain expertise in pharma/biotech compliance (cGMP, 21 CFR Part 11) creates switching costs [22]
• Labour training moat: Company establishing a learning centre at its facilities and tying up with universities to address industry-wide labour shortages [58]
• Time to replicate: Significant — manufacturing facility, FM Global certification, and 20+ years of accumulated domain knowledge [22] [28]

6. Customer Profile

Customer Segments — Order Book by End-Industry

Sources: [56] [4] [23] [26]

Key trend: Rapid diversification from pharma-dominant to renewable energy-led. Pharma fell from ~67.6% [Jul 2025] to ~24.9% [Feb 2026] of the order book, while renewable energy became the majority contributor at ~53.1%.

The order book's pivot from pharma-dominated (67.6%) to renewable energy-led (53.1%) in just eight months reflects opportunistic large-order capture rather than a structural shift in end-market mix. The ₹68 crore single solar order alone drove much of this swing. If recognised revenue follows this pattern, FTCL's pharma domain moat — its core differentiator — may be underutilised while the company competes on price in a less specialised segment.

Order Pipeline (Under Negotiation) [Feb 2026]

Source: [26]

An earlier pipeline snapshot [Jul 2025] showed ₹439.56 crore under negotiation with significant semiconductor exposure (₹159.16 crore) [56].

Earnings call pipeline [Jun 2025]: Pharma ₹137 crore (modular partition path only — turnkey path not yet fully tapped), Semiconductor ₹118 crore, Solar ₹80 crore, Data Centres ₹15.5 crore; total ~₹350 crore [51].

Named Clients

Customer Concentration

• Largest single order: ₹68 crore from one solar PV manufacturer — represented ~41% of the Sep 2025 order book [5] [4]. This indicates significant single-client concentration risk on the order book.
• Related-party concentration: Sales to FTL (₹15.23 crore) + UAE entities (₹12.21 crore) totalled ₹28.16 crore or ~20.2% of standalone revenue [FY25] [69].
• Top 5 / Top 10 concentration: Not disclosed quantitatively.

Relationship Depth

Acquisition Model

Primarily reference-driven + field sales + tender/LOI-based. The company participates in industry exhibitions (increased spend on sales promotion for semiconductor and alternative energy sectors in H1 FY26) [39] and leverages project references to acquire new clients across sectors [39]. Management described their approach as "expanding both feet on the ground and brains in the boardroom pan-India" [56].

Sector-Specific Metrics (Manufacturing B2B / Cleanroom Infrastructure)

Competitive Distribution Comparison

Competitive Landscape

Management identified the following competitors [22] [29]:

FTCL's claimed advantages vs. competitors [22] [52]:

1. Integrated model — most competitors are pure contractors; FTCL is designer + manufacturer + project manager
2. Manufacturing scale — stated volume barriers for new entrants
3. In-house pharma domain expertise — R&D professionals, pharma scientists on team
4. Consolidation tailwind — Japanese acquisitions of four Indian competitors have reduced the independent competitive field
5. Industry consolidation strategy — management is actively pursuing acquisitions: "you will see a lot of consolidation happening" [58]

Data gap: Quantitative peer comparison on revenue, margins, geographic coverage, and distribution reach is not available from the filings. All competitors are unlisted entities.

The acquisition of four Indian competitors by Japanese firms (Takasago, Shinryo) validates the strategic value of domestic cleanroom capabilities, but also signals that well-capitalised international players are building integrated India presence. FTCL's own M&A-driven consolidation strategy positions it as either a long-term survivor or, given its SME scale, a potential acquisition target itself.

Key Data Gaps

1. Segment-wise revenue breakdown is not reported — single segment under AS-17 [60]. Revenue by end-industry (pharma vs. solar vs. semiconductor) is available only for order inflows, not recognised revenue.
2. Customer concentration metrics (top 1 / top 5 / top 10 % of revenue) are not disclosed.
3. Channel margins and credit terms with clients are not disclosed.
4. Geographic revenue split (domestic vs. export) is available only at standalone level; consolidated export data is not separately reported.
5. Competitor financials for a quantitative distribution comparison are not available — all competitors are private/unlisted.
6. Logistics and warehousing model is not disclosed.
7. Related-party pricing methodology — while described as "arm's length" [64], the quantum of related-party sales (~20% of standalone revenue) warrants ongoing monitoring.